Inspira Technologies and Sheba Medical Center Collaborate on Breakthrough Respiration Treatment
USA - English
News provided by
Share this article
Share this article
RA ANANA, Israel, Feb. 17, 2021 /PRNewswire/ Inspira Technologies Ltd. announced today that it is collaborating with the Sheba Medical Center, ranked by Newsweek magazine as one of the top 10 hospitals in the world, to test its innovative blood oxygenation technology.
The intensive care unit (ICU) of the Department of Cardiac Surgery at Sheba Hospital will test Inspira s Augmented Respiration Technology (ART). The technology will be used on critically ill COVID-19 patients.
ART is the
world s first technology to oxygenate blood directly as a first line support. It uniquely fills a gap in respiratory treatment where supplemental respiratory therapies such as high-pressure masks are insufficient and the risks from mechanical ventilation such as medically-induced comas, intubation, and lung atrophy are unjust
real hot yoga is Heating Up the Franchise World
News provided by
Share this article
Share this article
KNOXVILLE, Tenn., Feb. 17, 2021 /PRNewswire/ The real hot yoga brand is setting their sights on expansion through franchised locations. With 6 hot yoga studios currently under their corporate umbrella, the yoga concept recognized the continued demand of yoga enthusiasts for more studio locations. Despite Covid-19, real hot yoga has seen strong signs of growth, and is seeking strategic franchisees to be a part of their emerging brand.
One of the founding partners, Cindy Coats, shared what is so special about real hot yoga. She said, Boutique fitness has experienced some of its darkest days, in result of the pandemic. Now, more than ever, we believe that people need yoga in their life. Our fitness approach to yoga makes it less foreign and more accessible to more people. With a wide variety of different styles of yoga and yoga hybrid classes, real hot yoga is a one stop sho
Asia Pacific Bone Grafts & Substitutes Market to 2027 by Product (Allograft, Synthetic) & Application (Spinal Fusion, Dental, Craniomaxillofacial, Foot & Ankle, Joint Reconstruction, Long Bone)
News provided by
Share this article
Share this article
Asia Pacific Bone Grafts & Substitutes Market Growth & Trends
The Asia Pacific bone grafts and substitutes market size is expected to reach USD 922.4 million by 2027, expanding at a CAGR of 7.1%.
Increasing the incidence of bone disorders due to road accidents and sports injuries is driving the market. Increasing demand for the development of biocompatible bone grafts in order to reduce adverse reaction is driving demand for synthetic grafts.
The industry players are continuously trying to develop new products with better biocompatibility, bioactivity, and suitable mechanical properties. For instance, in June 2019, Biogennix received 510(K) clearance from USFDA for Agilon, which is fully biocompatible with human bone.
Innovaccer Expands Executive Leadership Team to Support Rapid Growth
New leaders bring decades of experience from multiple sectors to drive market expansion and help healthcare organizations care as one.
News provided by
Share this article
Share this article
SAN FRANCISCO, Feb. 17, 2021 /PRNewswire/ Innovaccer, Inc., a leading healthcare technology company, recently announced the expansion of its leadership team with two new executives, adding decades of experience and additional leadership capacity to support the company s rapid growth and diversification. Innovaccer s newest executives include Andy Burtis, Chief Marketing Officer, and Dan Guggenheim, Chief Legal Officer.
As Innovaccer s Chief Marketing Officer,
Andy Burtis will lead the evolution of Innovaccer s brand strategy, while also driving the company s product marketing, content marketing, and demand generation activities. Andy has more than 20 years of experience in B2B marketing, including CMO roles at C3.ai an
Share this article
Share this article
WASHINGTON, Feb. 17, 2021 /PRNewswire/ U.S. News & World Report, the global authority in hospital rankings, will convene leading children s health experts for Pediatric Priorities: Improving Children s Health in the COVID-19 Era, a virtual event series underwritten by Texas Children s Hospital and focused on some of the most pressing issues facing pediatric providers, parents and young people.
The monthlong program will kick off on Feb. 23 with a
webinar exploring the impact of the ongoing COVID-19 pandemic on children s health and pediatric hospitals around the country, along with new insights on multisystem inflammatory syndrome in children (MIS-C) from Dr. Lara Shekerdemian, chief of critical care at Texas Children s.